Showing 21-30 of 32 grants

Title Institution Researcher Program Duration Total Award Amount
Tracking disease progression in early stage T1D using an automated version of the oral minimal model Cardiff University Colin Dayan Cures 01-August-2023 to 31-July-2026 $2.249.997,56
Biological Signature of Diabetes Mellitus University of Cambridge Kourosh Saeb-Parsy Cures 01-August-2023 to 31-July-2026 $514.959,00
Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 1 diabetes mellitus University of Ulster Alexander Miras Improving Lives 01-July-2023 to 31-May-2026 $350.884,00
My T1D Care Tool: Co-Creating a digital psychosocial measure for young people living with Type 1 Diabetes as part of routine healthcare management Queen's University Belfast Emma Berry Improving Lives 01-July-2023 to 30-June-2026 $109.958,00
Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes University of Exeter Chloe Rackham Cures 01-April-2023 to 31-March-2026 $375.000,00
Provision of normal and diabetic pancreatic tissue and islets for basic research (Oxford JDRF Human Islet Resource Centre) University of Oxford Paul Johnson Cures 01-September-2022 to 31-January-2026 $189.548,48
Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST) University of Dundee Ify Mordi Improving Lives 01-September-2023 to 31-August-2026 $1.783.962,00
Developing The Translational Potential Of The NPY Y4 Receptor For Treating Type 1 Diabetes King's College London Gavin Bewick Cures 01-June-2022 to 30-November-2026 $960.119,92
T1D Plus: a clinical trial platform for combined beta cell preservation therapy Cardiff University Colin Dayan Cures 01-September-2022 to 31-August-2026 $2.605.623,32
Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study University of Birmingham Parth Narendran Cures 01-March-2022 to 31-August-2025 $585.569,82